EFC 5826 Randomized, multinational, multicenter, double-

Project: Research project

Project Details

Description

Randomized, multinational, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20 mg OD for reducing the risk of major cardiovascular events in abdominally obese patients with clustering risk factors
StatusFinished
Effective start/end date6/16/068/3/10

Funding

  • SANOFI-AVENTIS US

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.